Pharmacy school teaches drug interactions, dosage calculations and law. It does not teach how to hire a finance team, negotiate with investors or keep a company’s culture intact while headcount climbs. Christian Stella learned that part on the job.
The shift he saw
Stella, a fourth-generation pharmacist who earned his PharmD from St. John’s University in 2016, watched compounding move online. Traditional compounding pharmacies had spent decades serving patients through local doctors and in-person consultations. Telehealth was changing how prescriptions were written and delivered, and in his view the pharmacy infrastructure behind it was not keeping pace.
He and his co-founders built Precision Medicine, a Bellmore, New York, pharmacy that fills prescriptions for telehealth companies, connects to their systems through APIs and ships directly to patients.
Growth and its costs
The company scaled quickly. A Digital Journal profile in August 2026 reported that it now operates three fulfillment centres, in New York, Florida and California, and serves patients across 49 states. Growing that fast meant raising venture capital, and Stella worked with peer groups and his board to manage the challenges.
According to the profile, hypergrowth taught him more about leadership than about the pharmacy business itself.
Lessons for founders in regulated industries
Compliance scales slower than sales. In pharmacy, every new state means a new licence. Revenue can grow in a quarter. Licensing can take much longer. Founders in regulated fields have to plan growth around the slowest approval, not the fastest customer.
Hire for the job the company will need. A pharmacist-founder can run a single pharmacy. A multistate operation needs executives in compliance, finance, technology and operations. Precision Medicine’s leadership page lists a vice president of compliance, an executive vice president of finance and technology, and a chief operating officer who is also a PharmD.
Use a board and peers. Stella leaned on his board and peer groups during rapid growth. Founders who try to carry every decision alone tend to slow down exactly when speed matters.
Redundancy is strategy. Precision Medicine’s website says it runs multiple locations for redundancy and faster turnaround. In a business where a shipping delay affects a patient, a second and third site are operating insurance.
Patience is a skill. Stella failed his first licensing exams and waited six months to retest. He has described that stretch as a gift that gave him patience. Hypergrowth rewards speed, but regulated industries punish shortcuts.
The ambition ahead
Stella has said he wants Precision Medicine to become the defining name in direct-to-consumer telehealth fulfillment, a “true pharmacy unicorn,” in his words to Digital Journal.
Whether or not it gets there, his path shows a pattern worth noting: technical founders in healthcare often find that the hardest problems are organisational, and that leadership becomes the main job long before the product feels finished.
